Paclitaxel, cisplatin and etoposide combination chemotherapy: a comparison of dose intensity in two multifractionated dose schemas

By Lokich J.   Anderson N.   Moore C.   Bern M.   Coco F.   Sonneborn H.   Dow E.   Strong D.  

European Journal of Cancer, Vol. 34, Iss. 5, 1998-04 ,pp. : 664-667

Elsevier

Access to resources Recommend Favorite

The Efficacy of prophylactic Shakuyaku-Kanzo-to for myalgia and arthralgia following Carboplatin and Paclitaxel combination chemotherapy for non-small cell lung cancer

By Yoshida Tsutomu  

Supportive Care in Cancer, Vol. 17, Iss. 3, 2009-03 ,pp. : 315-320

Springer Publishing Company

Access to resources Recommend Favorite

Comparative analysis of carboplatin and paclitaxel combination chemotherapy schedules in previously untreated patients with advanced non-small cell lung cancer

By            

Oncology Letters, Vol. 5, Iss. 3, 2013-01 ,pp. : 761-767

Spandidos Publications

Access to resources Recommend Favorite

Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer - a phase II trial

By Laack E.   Mende T.   Durk H.   Kneba M.   Dickgreber N.   Welte T.   Muller T.   Scholtze J.   Graeven U.   Jasiewicz Y.   Edler L.   Hossfeld D.K.  

European Journal of Cancer, Vol. 38, Iss. 5, 2002-03 ,pp. : 654-660

Elsevier

Access to resources Recommend Favorite

Triplet chemotherapy combination with cisplatin, gemcitabine and docetaxel in patients with chemotherapynaive advanced non-small cell lung cancer

By          

Oncology Letters, Vol. 5, Iss. 5, 2013-01 ,pp. : 1699-1703

Spandidos Publications

Access to resources Recommend Favorite